ABSTRACT
The type VI secretion system (T6SS) and hemolysin HlyA are important virulence factors in Vibrio cholerae. The forkhead-associated (FHA) domain is a conserved phosphopeptide binding domain that exists in many regulatory modules. The FHA domain protein-encoding gene is conserved in the T6SS gene cluster and regulates the assembly and secretion of the T6SS. This study shows for the first time that the FHA domain protein TagH plays a role in controlling the hemolytic activity of V. cholerae, in addition to regulating the T6SS. TagH negatively regulates HlyA expression at the transcriptional and post-translational levels. The phosphopeptide binding sites of the FHA domain of TagH play a key role in the regulation of hemolytic activity. The deletion of tagH enhances the intestinal pathogenicity and extraintestinal invasion ability of V. cholerae, which mainly depend on the expression of HlyA. This study provides evidence that helps unravel the novel regulatory role of TagH in HlyA and provides critical insights which will aid in the development of strategies to manage HlyA.
KEYWORDS: Vibrio cholerae, forkhead-associated domain, TagH, type VI secretion system, hemolysin
Introduction
Vibrio cholerae mainly exists in aquatic environments and can be transmitted to human hosts through the ingestion of contaminated food or water.1,2 Based on its surface O antigens, V. cholerae can be classified into more than 200 serotypes.3 Cholera epidemics or pandemics are only caused by the O1 and O139 serogroups, and the non-O1/non-O139 serogroups are mainly associated with gastroenteritis or parenteral infections, such as bacteremia,4 skin and soft tissue infections,5 and meningitis.6,7 Notably, non-O1/non-O139 V. cholerae bacteremia is a serious disease with high mortality, and is considered a global health threat, especially in patients with a history of alcohol abuse and/or cirrhosis. However, its pathogenic mechanisms are currently unclear. In the previous two decades, invasive infections caused by non-O1/non-O139 V. cholerae have increased, and are significantly higher than the number of reported O1 and O139 V. cholerae cases.8 The O1, O139, and non-O1/non-O139 V. cholerae strains have varying numbers of virulence factors, and this is thought to be the reason for the differences in their clinical results.9,10 The main pathogenic factors of O1 and O139 strains are cholera toxin (CT) and toxin-coregulated pili (TCP).11,12 In contrast, non-O1/non-O139 strains do not contain CT and TCP, and their virulence mechanisms are not yet well defined.13,14 However, additional virulence factors such as the type III secretion system (T3SS), heat-stabilized enterotoxin, hemolysin (HlyA), mannose-sensitive hemagglutinin, and the type VI secretion system (T6SS) have been identified in non-O1/non-O139 strains.9,15
V. cholerae HlyA is an important virulence factor that belongs to the pore-forming toxin family, produced in the El Tor biotype and most non-O1/non-O139 isolates.16,17 HlyA has vacuolar and cytocidal activity in many cell lines,18,19 and is associated with rapid mortality in mice.20,21 In addition, in non-O1/non-O139 V. cholerae, HlyA has been shown to be a contact-independent competitive factor in the ecological niches.22 The T6SS is another key contact-dependent weapon that can directly kill competitors through the translocation of effectors. V. cholerae was one of the first bacteria in which a T6SS was identified, and it has now been found in all sequenced isolates of V. cholerae.2,23 It is a multi-component toxin delivery device that is structurally and functionally analogous to the T4 bacteriophage tail spike.24,25 The T6SS not only plays an important role in inter- and intra-species competition in the aquatic environment and host life cycle but also contributes to virulence and intestinal colonization.22,25–29
The forkhead-associated (FHA) domain is a phosphopeptide binding module,30,31 which is found in many regulatory proteins in both eukaryotes and bacteria. However, the functions of the FHA domain proteins in bacterial physiology remain unclear. The FHA domain has previously been found to play a variety of roles in bacteria such as cell shape regulation, pathogenicity, host-bacterial interaction, and type III secretion.31,32 Interestingly, many of the T6SS gene clusters encode orthologs of the FHA-associated domain-containing proteins, serine-threonine kinase (PpkA) and serine-threonine phosphatase (PppA), which are involved in the regulation of threonine phosphorylation events. For example, in Pseudomonas aeruginosa and Serratia marcescens, PpkA and PppA regulate the threonine phosphorylation and dephosphorylation of FHA domain proteins, respectively, and this affects the assembly and secretion of the T6SS.26,30,33,34 However, genomic sequence analysis found that some bacterial T6SS gene clusters were contained only in the FHA domain protein coding genes without PpkA and PppA coding genes, such as those of V. cholerae, E. coli O157, and Y. pestis.35,36 The biological function of the FHA domain protein in these bacteria is not fully understood. Only one gene in the V. cholerae genome encodes the FHA domain protein, and it is present in the T6SS gene cluster; its encoded protein is annotated as the T6SS-associated FHA domain protein TagH, and it contains a 93 aa FHA domain (aa 8–110). Since the ppkA and pppA genes have not been found in the genome of V. cholerae, the function of TagH is currently unclear.34,36 It was also previously shown that T6SS hallmark protein Hcp cannot be secreted in the VCA0112 (tagH) mutant, suggesting that TagH is required for the T6SS to function in V. cholerae.37 In this study, we found that TagH plays a previously unrecognized role in controlling V. cholerae hemolytic activity and virulence, in addition to regulating the T6SS.
Results
TagH represses hemolytic activity and cytotoxicity in V. cholerae
Previously, an FHA domain-containing protein was shown to contribute to Hcp secretion in the V. cholerae O37 serogroup strain V5237. In this study, a tagH mutant (ΔtagH) was constructed in the non-O1/non-O139 V. cholerae HN375 strain. Interestingly, we found that the hemolysis zone for the ΔtagH mutant on sheep blood agar was significantly larger than that for the wild-type strain (Figure 1a). Since V. cholerae lyses red blood cells by secreting hemolysin, we collected the culture supernatant of each strain to further investigate hemolysis. The results showed that the hemolytic activity of the ΔtagH strain was significantly higher than that of the wild-type (Figure 1b). The hemolytic activity of the complemented mutant ΔtagH::tagH was restored to the wild-type level (Figure 1b). The pBAD24 empty plasmid did not restore the hemolytic activity of the ΔtagH strain. These data suggest that TagH may be a negative regulator of V. cholerae hemolysin. V. cholerae hemolysin is also an important cytotoxin, as it has previously been shown to have cytocidal activity against a variety of cell lines.38 We further tested the cytotoxicity of the culture supernatant for each strain at different dilution ratios with the SW480 cells (human colon adenocarcinoma cells). The results showed that when compared with the lysogeny broth (LB) medium, the supernatant of the wild-type strain reduced cell viability, while that of the ΔtagH mutant significantly decreased cell viability when compared with the wild-type (Figure 1c). Compared with the ΔtagH group, the cell viability of the complemented mutant ΔtagH::tagH culture supernatant was restored to the wild-type level, while the pBAD24 plasmid had no replenishment effect. Taken together, these data support the hypothesis that TagH negatively regulates the hemolytic and cytotoxic activities of V. cholerae. To further examine the effects of TagH on the activity of the T6SS, we analyzed the expression of Hcp in the culture supernatant and whole cell lysates. We found that Hcp secretion was abolished in the ΔtagH mutant, while in the complemented mutant ΔtagH::tagH it was restored to a level similar to that of the wild-type strain (Figure 1d). In addition, the expression level of intracellular Hcp was significantly increased in the ΔtagH mutant, while in T6SS null mutants ΔtssB and ΔtssM, it was similar to that of the wild-type strain (Figure 1d). These results suggest that tagH knockout affects the secretion and intracellular expression of Hcp in the non-O1/non-O139 V. cholerae HN375 strain.
Figure 1.

TagH negatively regulates the hemolytic and cytotoxic activities of V. cholerae. a The hemolytic zone of the wild-type (WT), ΔtagH, ΔtagHΔhlyA, ΔtssB and ΔtssM strains cultured on 5% sheep blood agar at 37°C for 24 h. b Hemolysis activity of the culture supernatants from the WT, ΔtagH, and complementary mutant ΔtagH::tagH. The culture supernatants and erythrocyte suspensions were mixed at a ratio of 9:1 and incubated at 37°C for 5 h. The supernatant was collected every hour to measure its absorbance at 540 nm. The relative hemolysis rates are shown as the means and standard errors of three biological replicates (n = 3). c Cytotoxicity of culture supernatants from various strains. SW480 cells were treated with WT, ΔtagH and ΔtagH::tagH culture supernatants with 5%, 10%, and 15% dilutions at 37°C for 8 h. The cell viability of the SW480 cells via the CCK-8 assay. The values are shown as means and standard errors of six biological replicates (n = 6). ***, P < .001 between two strains. d Western blotting analysis for the precipitated culture supernatants and whole cell lysates from the WT, ΔtagH, ΔtagH::tagH, ΔtssB and ΔtssM strains with anti-Hcp serum. A Coomassie blue stained gel was used to estimate the loading amount for each sample.
Regulation of the hemolytic activity and cytotoxicity in V. cholerae by TagH depends on the expression of HlyA
As HlyA is the predominant hemolysin in V. cholerae, we tested whether TagH regulates V. cholerae hemolytic activity and if cytotoxicity depends on the expression of HlyA. We constructed the ΔtagHΔhlyA double knockout strain and performed hemolysis and cytotoxicity experiments. These results showed that the hemolytic activity of the ΔtagHΔhlyA culture supernatant was almost completely lost; it was significantly lower than both that of the ΔtagH mutant and wild-type (Fig. 1a, 2a, and 2b). In addition, the cytotoxicity of the ΔtagHΔhlyA culture supernatant to the SW480 cells was significantly lower than that of the ΔtagH mutant and wild-type (Figure 2c). Western blotting was then performed to detect the expression of HlyA in the culture supernatant and whole cell lysates. The results showed that HlyA expression in the supernatant and whole cell lysates of the ΔtagH mutant was significantly higher than in the wild-type strain, and HlyA expression was restored to the wild-type level in the complementary mutant ΔtagH::tagH (Figure 2d). There was no HlyA expression in the ΔtagHΔhlyA double knockout strain. Mass spectrometry analysis confirmed that the blot band in the western blotting analysis was the HlyA protein (Supplementary Fig. 1). Taken together, these data support the hypothesis that TagH regulates the hemolytic activity and cytotoxicity of V. cholerae, which depend on the expression of HlyA. We then aimed to determine whether the impact of TagH on HlyA expression is a downstream consequence of the impaired secretions from the T6SS. We constructed T6SS null mutants ΔtssB (VCA0107) and ΔtssM (VCA0120),39 and detected the expression of HlyA. The results showed that both the tssB and tssM knockouts resulted in the loss of Hcp secretion (Figure 1d) and slightly decreased hemolytic activity (Figure 1a) and HlyA expression (Figure 2d), suggesting that the regulation by TagH of the hemolytic activity of V. cholerae may not depend on the integrity of the T6SS.
Figure 2.

TagH regulation of the hemolytic activity and cytotoxicity of V. cholerae depends on HlyA expression. a-b Hemolytic activity analysis of the culture supernatant isolated from the WT, ΔtagH, and ΔtagHΔhlyA strains against 1% rabbit red blood cells at 37°C for 5 h. LB was used as a negative control. The supernatant was collected every hour to measure absorbance at 540 nm. The relative hemolysis rates are shown as the means and standard errors of three biological replicates (n = 3). c Detection viability of SW480 cells using the CCK-8 assay. SW480 cells were treated with the WT, ΔtagH, and ΔtagHΔhlyA culture supernatants with 5%, 10%, and 15% dilutions at 37°C for 8 h. The values are shown as means and standard errors of five biological replicates (n = 5). ***, P < .001 between two strains. d Western blotting analysis for the precipitated culture supernatants and whole cell lysates from the WT, ΔtagH, ΔtagH::tagH, ΔtagHΔhlyA, ΔtssB and ΔtssM strains with anti-HlyA serum. A Coomassie blue stained gel was used to estimate the loading amount for each sample. All the experiments were independently repeated three times, and one representative result is shown.
TagH negatively regulates HlyA transcription, and may involve the subtle regulation of hlyU and fur
Previous studies have suggested that the expression of HlyA in V. cholerae is mainly regulated at transcriptional and post-translational levels.40,41 At the transcriptional level, hlyA transcription is mainly regulated by HapR, Fur, and HlyU.42 The quorum-sensing regulator HapR inhibits HlyA expression at the transcriptional and post-transcriptional levels.43 The iron uptake regulator Fur can inhibit the expression of the hlyA gene,44 while the HlyU protein is a positive regulator of the hlyA gene.45–47 To investigate whether transcriptional regulation is involved, the expression of hlyA at the transcriptional level was assessed using quantitative real-time PCR (qRT-PCR). The results showed that the transcription level of the hlyA gene in the ΔtagH mutant was approximately five times higher than that of the wild-type, and in the ΔtagH::tagH strain it was restored to the wild-type level (Figure 3a). This suggests that TagH can regulate the expression of the hlyA gene at the transcriptional level. We further screened the expression of the above-mentioned hlyA transcriptional factors in the wild-type, ΔtagH, and ΔtagH::tagH strains using qRT-PCR. The results showed that the transcription level of hlyU in the ΔtagH mutant was significantly higher than that in the wild-type (Figure 3b), while the transcription level of fur in the ΔtagH mutant was significantly lower than that in the wild-type (Figure 3c). The transcription levels of hlyU and fur in ΔtagH::tagH were restored to levels similar to those in the wild-type. These results suggest that the transcriptional regulation of hlyA by TagH may be involved in HlyU and Fur. In addition, the luminescence reporter assay was used to measure transcription changes of hlyA, hlyU, and fur genes. The results showed that the activity of the hlyA promoter was significantly upregulated in the ΔtagH mutant when compared to the wild-type, while the activity of the hlyA promoter in the ΔtagH::tagH mutant was restored to a level close to that of the wild-type (Figure 3d), which is consistent with TagH repression of hlyA transcription. Additionally, the promoter activities of hlyU and fur were significantly upregulated and downregulated, respectively, in the ΔtagH mutant when compared to the wild-type (Figure 3e, 3f); this was consistent with the results of the qRT-PCR. We further constructed ΔtagH+pBAD24-fur strains to restore fur expression as well as ΔtagHΔhlyU double-knockout strains and analyzed their hemolytic activity and hlyA transcription. The results showed that the hemolytic activity and hlyA transcription of ΔtagHΔhlyU were significantly lower than those of the ΔtagH mutant and the wild-type, while the hemolytic activity and hlyA transcription of ΔtagH+pBAD24-fur were partially restored compared with those of the ΔtagH strain (Figure 3g, 3h). Taken together, these results suggest that the regulation of hlyA transcription by TagH may be involved in the subtle regulation of HlyU and Fur.
Figure 3.

Regulation of hlyA transcription by TagH may involve the subtle regulation of HlyU and Fur. a-c qRT-PCR results for the relative mRNA levels of hlyA (a), hlyU (b), and fur (c) were compared between WT, ΔtagH, and ΔtagH::tagH strains. The values are shown as the means and standard errors of three biological replicates (n = 3). **, P < .01 and ***, P < .001 for the ΔtagH mutant relative to the wild-type strain. d-f The promoter activities were detected using a luciferase reporter assay. The luciferase activity of hlyA, hlyU, and fur were determined in the WT, ΔtagH, and ΔtagH::tagH strains. The values are shown as the means and standard errors of three biological replicates (n = 3). g qRT-PCR results for the relative mRNA levels of hlyA were compared between WT, ΔtagH, ΔtagHΔhlyU, and ΔtagH+pBAD24-fur strains. The values are shown as the means and standard errors of three biological replicates (n = 3). **, P < .01 and ***, P < .001 between two strains. h Hemolytic activity analysis of the culture supernatant isolated from the WT, ΔtagH, ΔtagHΔhlyU, ΔtagH+pBAD24-fur, and ΔtagH+pBAD24 strains against 1% rabbit red blood cells at 37°C for 5 h.
TagH regulation of HlyA expression may require protease PrtV at the post-translational level
Evidence has been presented for the transcriptional regulation of hlyA by TagH. At the post-translational level, HlyA is produced as a precursor protein (pro-HlyA), which is subsequently activated by a protease conducting two cleavage steps to produce the fully active form of hemolysin.40 However, prolonged incubation of HlyA with protease can lead to the degradation of HlyA.40,43 In V. cholerae, HapR can increase the expression of the metalloproteases HapA and PrtV, which can degrade HlyA.43 In this study, we also found that the transcription level of prtV in the ΔtagH mutant was significantly downregulated when compared to the wild-type, and its transcription level in the ΔtagH::tagH mutant was restored to that of the wild-type (Figure 4a), suggesting that the tagH deletion inhibits the transcription of prtV. To further explore whether the effects of TagH on the activity of HlyA might require the protease PrtV, we constructed a ΔtagHΔprtV double knockout mutant, restored the expression of PrtV in the ΔtagHΔprtV mutant (ΔtagHΔprtV::prtV) using the pBAD24-prtV plasmid, then tested their hemolytic activity and cytotoxicity. The results showed that the hemolytic activity of the ΔtagHΔprtV mutant supernatant was slightly higher than that of the ΔtagH mutant (Figure 4b), but the cytotoxicity of the two strains did not change significantly (Figure 4c). However, both the hemolytic activity and cytotoxicity of the ΔtagHΔprtV::prtV strain were significantly lower than those of the ΔtagH and ΔtagHΔprtV strains (Figure 4b and 4c). This suggested that TagH’s regulation of hemolytic activity and cytotoxicity may also be mediated by its regulation of PrtV expression. We further tested whether PrtV affected the expression of HlyA in the supernatant of the above strains using western blotting. HlyA was expressed at a similar level in the supernatants of the ΔtagH and ΔtagHΔprtV strains (Figure 4d, 4e). However, when PrtV was restored in the ΔtagHΔprtV strain, the expression of HlyA was significantly decreased in ΔtagHΔprtV::prtV when compared to that in ΔtagH and ΔtagHΔprtV mutants. These results are consistent with the results of the tests for hemolytic activity and cytotoxicity in the ΔtagH, ΔtagHΔprtV, and ΔtagHΔprtV::prtV strains. Cumulatively, these data suggest that PrtV may be involved in TagH regulation of HlyA expression at the post-translational level.
Figure 4.

PrtV may be involved in TagH regulation of HlyA expression at the post-translational level. a qRT -PCR results for the relative mRNA levels of prtV were compared between the WT, ΔtagH, and ΔtagH::tagH strains. The values are shown as the means and standard errors of three biological replicates (n = 3). ***, P < .001 for the ΔtagH mutant relative to the wild-type strain. b Hemolytic activity assay showing the hemolytic activity of the culture supernatants collected from the WT, ΔtagH, ΔtagHΔprtV, ΔtagHΔprtV-pBAD24 and the prtV complementary mutant ΔtagHΔprtV::prtV strains against 1% rabbit red blood cells at 37°C for 5 h. The supernatant was collected every hour to measure its absorbance at 540 nm. The relative hemolysis rates are shown as the means and standard errors of three biological replicates (n = 3). c Detection of SW480 cell viability using the CCK-8 assay. SW480 cells were treated with WT, ΔtagH, ΔtagHΔprtV, and ΔtagHΔprtV::prtV culture supernatants with 5%, 10%, and 15% dilutions at 37°C for 8 h. The values are shown as the means and standard errors of five biological replicates (n = 5). d Western blotting analysis of the precipitated supernatant proteins of the WT, ΔtagH, ΔtagHΔprtV, and ΔtagHΔprtV::prtV strains with anti-HlyA serum. The Coomassie-stained gel was used as a loading control. e The relative protein expression levels of HlyA were quantified according to the western blotting bands using ImageJ software. The values are shown as the means and standard errors of three biological replicates (n = 3). **, P < .01 and ***, P < .001; NS, not significant.
Putative phosphopeptide binding residues of TagH play a key role in regulating HlyA expression
Structural studies have shown that several conserved FHA domain residues directly bind to the phosphate moieties and play key roles in their interactions with phosphorylated substrates.33,48,49 TagH sequence alignments with other FHA domain-containing proteins revealed that its FHA domain also contains conserved residues related to phosphopeptide binding (S38 and K54) (Figure 5a). To test whether these conserved phosphopeptide binding residues are also related to TagH’s regulation of the hemolytic activity in V. cholerae, we constructed various tagH mutants, including alanine substitution mutants at the Ser 38 residue (TagHS38A), Lys 54 residue (TagHK54A), and at both the Ser 38 and Lys 54 residues (TagHS38AK54A). The hemolytic activity was completely restored in the ΔtagH::tagH strain by the non-mutated pBAD24-tagH plasmid, whereas the hemolytic activity of the ΔtagH::tagHS38A, ΔtagH::tagHK54A, and ΔtagH::tagHS38AK54A mutants increased successively, and they were all significantly higher than those of the complementary mutant ΔtagH::tagH (Figure 5b, 5c). This indicates that the putative phosphopeptide binding residues (S38 and K54) of TagH may be critical for the regulation of hemolytic activity in V. cholerae. Western blotting analysis also showed that the expression levels of HlyA in the supernatant of the ΔtagH::tagHS38A, ΔtagH::tagHK54A, and ΔtagH::tagHS38AK54A strains increased successively. HlyA secretion was not restored in the ΔtagH::tagHS38AK54A strain, whereas in ΔtagH::tagHS38A and ΔtagH::tagHK54A it was partially recovered when compared to that in ΔtagH (Figure 5d, 5e), which was consistent with the hemolysis phenotype. Additionally, we found that compared with the non-mutant, the S38A and K54A single-point mutants and the S38AK54A double-point mutant significantly inhibited the secretion of Hcp (Figure 5d). Taken together, these data support the hypothesis that the putative phosphopeptide-binding residues play a key role in regulating HlyA expression and Hcp secretion in V. cholerae. Since no conserved PpkA and PppA were found in V. cholerae, it is not clear if TagH can be phosphorylated. We used Phos-tag SDS-PAGE to separate phosphorylated and unphosphorylated proteins on a gel, and western blotting was performed using an anti-His-tag antibody. The results showed that there was only one TagH protein band (Figure 5f). We attempted to further identify potential phosphorylation sites in TagH by mass spectrometry, but no sites were identified (Supplementary Table 1). These data suggest that there is no phosphorylated phenotype of TagH.
Figure 5.

Conserved phosphopeptide binding residues of TagH are required for the expression of HlyA and Hcp in culture supernatant. a A partial sequence alignment of TagH with selected FHA domain family proteins. Conserved phosphopeptide binding residues are indicated with an arrow, and S38 and K54 were used for mutagenesis. b-c Hemolytic activity assay results showing the activity of the culture supernatant isolated from the WT, ΔtagH, ΔtagH::tagH, ΔtagH::tagHS38A, ΔtagH::tagHK54A, and ΔtagH::tagHS38AK54A strains against 1% rabbit red blood cells at 37°C for 5 h. The supernatant was collected every hour to measure its absorbance at 540 nm. The relative hemolysis rates are shown as the means and standard errors of three biological replicates (n = 3). d Western blotting analysis of the precipitated supernatant proteins of the WT, ΔtagH, ΔtagH::tagH, ΔtagH::tagHS38A, ΔtagH::tagHK54A and ΔtagH::tagHS38AK54A strains with anti-HlyA and anti-Hcp serum. The Coomassie-stained gel was used as a loading control. All the experiments were independently repeated three times, and one representative result is shown. e Relative protein expression levels of HlyA quantified according to the western blotting bands using ImageJ software. The values are shown as the means and standard errors of three biological replicates (n = 3). **, P < .01; NS, not significant. f TagH phosphorylation analysis using Phos-tag SDS-PAGE. Different volumes of the His-tag-TagH protein in the ΔtagH::tagH mutant were separated on a 10% Phos-tag SDS-PAGE and examined using a specific anti-His-tag antibody. The Coomassie-stained gel was used as a loading control.
tagH mutants enhance the enterotoxicity of V. cholerae in rabbit ileal loops
To investigate the contributions of TagH, HlyA, and PrtV to the enterotoxicity of V. cholerae, we examined the enterotoxicity of the wild-type, ΔtagH, ΔtagHΔhlyA, and ΔtagHΔprtV strains in rabbit ileal loops. After 18 h of infection, the fluid accumulation (FA) in each loop was measured. The FA ratios for the wild-type, ΔtagH, ΔtagHΔhlyA, and ΔtagHΔprtV strains were not significantly different (Figure 6a). Histological analysis showed that when compared with the phosphate-buffered saline (PBS) control (Figure 6c), the rabbit ileal loops treated with the wild-type strain showed shorter villus length (Figure 6b) and crypt depth, hyperemia, and neutrophil infiltration in the submucosa (Figure 6d). Sections from tissues infected with the ΔtagH mutant showed more severe diffuse necrotizing enteritis, characterized by an almost complete loss of the villous structure, denudation of the surface epithelium in some sections, massive neutrophil infiltration in the submucosa, and crypt hyperemia and expansion (Figure 6e). Rabbit ileal loops treated with the ΔtagHΔhlyA mutant showed no significant intestinal histopathological changes (Figure 6f), and the villus lengths were not significantly different from those of the PBS group (Figure 6b). The ileal loops treated with ΔtagHΔprtV had slightly weaker intestinal pathological changes and longer villous lengths when compared with the ΔtagH mutants infected group (Figure 6b, 6g). Taken together, these results strongly suggest that the tagH deletion mutant enhances the enterotoxicity of V. cholerae, which mainly depends on HlyA, and that PrtV has a weaker effect.
Figure 6.

Deletion of tagH enhances the enterotoxicity of V. cholerae, which depends on HlyA. a The loop fluid volume (mL)/length (cm) ratio of rabbit after infection with 1 × 108 CFU of the WT, ΔtagH, ΔtagHΔhlyA, and ΔtagHΔprtV strains, n = 5. b Intestinal villus length was measured using ImageJ software, n = 30. c-g Histological damage in the rabbit ileal loop treated for 18 h with 1 × 108 CFU of the WT (d), ΔtagH (e), ΔtagHΔhlyA (f), and ΔtagHΔprtV (g) strains (H&E staining, 100 ×). PBS (c) was used as a negative control. ***, P < .001 between two strains. All scale bars = 100 µm.
tagH mutants enhance the extraintestinal pathogenicity of V. cholerae dependent on HlyA in the sepsis model
In this study, a sepsis model was established by intraperitoneal infection of V. cholerae to determine whether the tagH mutant affects the extraintestinal pathogenicity of the non-O1/non-O139 V. cholerae. The results showed that the survival rates of mice infected with the wild-type, ΔtagH, ΔtagHΔhlyA, and ΔtagHΔprtV strains were 50%, 0%, 75%, and 12.5%, respectively (Figure 7a). Surprisingly, all mice in the ΔtagH infection group died within 17 h, but in the ΔtagHΔhlyA infection group only one mouse died within 17 h. These results strongly suggest that the tagH deletion mutant enhances the extraintestinal pathogenicity of V. cholerae, which depends on HlyA. There was no significant difference in the average survival time and survival rate of the mice infected with the ΔtagHΔprtV and ΔtagH strains, suggesting that the effect of the PrtV is not significant in the extraintestinal pathogenicity of non-O1/non-O139 V. cholerae. Mouse blood samples were collected at 6 h and 12 h after bacterial infection for bacterial load analysis. The blood bacterial load of the mice infected with the ΔtagH strain was significantly higher than that of the wild-type (Figure 7b, 7c). Only one mouse in the ΔtagHΔhlyA infection group was found to have bacteria in its blood at 6 h. The average bacterial load in the blood of mice infected with the ΔtagHΔprtV strain was not significantly different from that of the ΔtagH infection group. These data provide further evidence that HlyA is the main contributor to the enhanced extraintestinal invasiveness of the ΔtagH mutants.
Figure 7.

HlyA is the main contributor to the enhanced invasiveness of ΔtagH mutants. a The survival rates of mice after infection with 1 × 107 CFU of the WT, ΔtagH, ΔtagHΔhlyA, and ΔtagHΔprtV strains, n = 8. b-c Bacteria numbers in the blood samples of mice after infection with 1 × 107 CFU of the WT, ΔtagH, ΔtagHΔhlyA, and ΔtagHΔprtV strains for 6 h (b) and 12 h (c). The data are expressed as the mean log10 CFUs of per mL blood samples (± SD, n = 8). **, P < .01 and ***, P < .001; NS, not significant.
Histological analysis showed that when compared with the PBS control group (Figure 8a), the lung tissue of the wild-type infection group had thickened alveolar walls, infiltration of inflammatory cells into the alveolar space, interstitial edema, and lung congestion (Figure 8b). When compared with the wild-type infection group, the ΔtagH infected mice had significantly increased lung injury, characterized by more alveolar wall congestion and septal widening, as well as increased neutrophil infiltration (Figure 8c). In the ΔtagHΔhlyA infected mice (Figure 8d), only a small number of inflammatory cells were observed in the bronchial tube pulmonary alveoli. Pathological damage in the lungs of the ΔtagHΔprtV infected mice (Figure 8e) was slightly weaker than that in the ΔtagH infected mice. In addition, we found that the liver tissue of the mice infected with the ΔtagH mutant had the highest infiltration of inflammatory cells when compared to the other groups, and focal necrosis of the liver cells was observed (Figure 8c). The infiltration of inflammatory cells in the liver tissue of the ΔtagHΔprtV mutant infected group (Figure 8e) was slightly higher that of the wild-type group (Figure 8b), while no obvious inflammatory change was observed in the ΔtagHΔhlyA infected group (Figure 8d). Notably, mice infected with ΔtagH and ΔtagHΔprtV mutants showed extensive atrophy of glomerular capillary loops and mild proliferation of mesangial stroma and mesangial cells (Figure 8c and 8e). WT and ΔtagHΔhlyA infected groups showed no obvious pathological changes (Figure 8b and 8d). Collectively, these results suggest that the ΔtagH mutant can significantly enhance the extraintestinal invasion ability and pathogenicity of V. cholerae, and HlyA is the main contributor to this process.
Figure 8.

Deleting tagH enhances the extraintestinal pathogenicity of V. cholerae, which depends on HlyA. Hematoxylin and eosin stained sections of mice lungs, livers, and kidneys challenged after infection with 1 × 107 CFU of WT (b), ΔtagH (c), ΔtagHΔhlyA (d), and ΔtagHΔprtV (e) strains for 12 h. The PBS (a) treatment group was used as a negative control. Sections were photographed at 200 × magnification. All scale bars = 50 µm.
Discussion
In this study, we identified for the first time that TagH plays an important role in controlling V. cholerae hemolytic activity and virulence, in addition to regulating the T6SS. Previous studies have shown that Thr phosphorylation events in the FHA domain protein regulate its binding to phosphorylated substrates in P. aeruginosa33,50 and S. marcescens,51 which has a key role in the T6SSs assembly and secretions. However, while Agrobacterium tumefaciens can encode PpkA and PppA, the phosphorylation target of its PpkA is not Fha but TssL.49 T6SS activation and secretion requires the interaction of the pThr-binding motif of Fha and phosphorylated TssL. In this study, we also confirmed that tagH knockout can inhibit Hcp secretion, which is consistent with previous reports.37 Interestingly, unlike T6SS null mutants ΔtssB and ΔtssM, we found that tagH knockout can significantly increase intracellular Hcp expression (Figure 1d), which may be due to the regulation of Hcp expression by HlyU. Previous studies reported that the expression of both HlyA and Hcp proteins depended on HlyU.52 In V. cholerae it is currently unknown if, due to the absence of PpkA, TagH can be phosphorylated, and we were unable to detect any phosphorylation in TagH (Figure 5f and Supplementary Table 1). However, we found that the conserved phosphopeptide binding sites (S38 and K54) of TagH were critical for HlyA expression and T6SS secretion. These results suggest that the binding of the FHA phosphopeptide domain to the phosphorylated substrate may be more conserved and extensive than its own phosphorylation events among different bacteria. Notably, the ΔtagH::tagHK54A mutant had a stronger effect on HlyA expression and Hcp secretion than ΔtagH::tagHS38A. Similar results were found in Pseudomonas aeruginosa, showing that the Fha1S48A mutation (corresponding to TagHK54A) causes more Hcp secretion defects than the Fha1R32A mutation (corresponding to TagHS38A).33 These results suggest that the conserved phosphopeptide binding residue K54 may have a more important role than the S38 residue in the binding of phosphorylated substrates. Although our data showed that TagH could regulate the transcription of genes such as hlyA, hlyU, fur, and prtV, no typical DNA-binding domains were found in the TagH sequence. However, its conserved phosphopeptide binding sites play a critical role in the regulation of HlyA expression. Therefore, we speculate that TagH regulation of the hemolytic activity of V. cholerae may be indirect, and it may depend on the binding of the FHA domain to the phosphorylated substrate.
A review of previously published data showed that HlyA is strictly controlled by multiple regulatory factors at the transcriptional and post-translational levels.40,42,43 At the transcriptional level, our results showed that the deletion of tagH significantly upregulated the transcription and promoter activity of hlyA and hlyU and downregulated fur transcription (Figure 3). The binding site of HlyU in the promoter region of hlyA is located at −563···−627, while the binding site of Fur in the promoter region of hlyA is located at −545··· −59642, indicating that two binding sites partially overlap. Therefore, we speculate that the transcriptional regulation of hlyA by TagH may depend on the subtle coordination of HlyU and Fur, which is consistent with a previous report.42 Furthermore, a previous study found that HlyA was highly expressed in the early stages of logarithmic growth,42 and our research mainly focused on this stage. At the post-translational level, several proteases have been shown to be involved in the activation and degradation of HlyA in V. cholerae.40 Vibrio mimicus has also been shown to display a very similar phenomenon, in which endogenous metalloproteases cleave and activate hemolysin at an early stage but inactivate hemolysin after further incubation.53 PrtV of V. cholerae is a Zn2+-binding extracellular protease belonging to the M6 metalloprotease family.54,55 HlyA is a substrate of the PrtV protease, and PrtV is the main contributing factor to HlyA inactivation.56 Our data showed that the tagH knockout significantly inhibited the transcription of the prtV gene (Figure 4a), and the ΔtagHΔprtV mutant only slightly increased HlyA expression when compared to the ΔtagH mutant (Figure 4d). We speculate that the tagH knockout inhibits prtV transcription at a very low level (approximately 16% of the wild level), resulting in no further impact on HlyA expression when prtV is knocked out in the context of the ΔtagH mutants.
Although purified HlyA has been reported to induce fluid accumulation (FA), it was also found that the amount of FA varies in the different parts of the intestine.57 In addition, during V. cholerae infection, other virulence factors, such as CT-like enterotoxin, can induce FA production, which interferes with the amount of FA induced by HlyA.58 Therefore, the amount of FA may not be a good indicator of the intestinal toxicity of V. cholerae. A previous study also found that there was no significant difference in the amount of FA between the V. cholerae El Tor biotype and its hlyA knockout mutants, but there was a significant difference in the degree of pathological damage.56 In this study, the rabbit ileal loop infection experiment results showed that the tagH knockout could enhance V. cholerae damage to the intestinal tissue, and this process mainly depended on HlyA (Figure 6), as the ΔtagHΔhlyA strain did not cause intestinal injury. Previous studies have also shown that the deletion of the hlyA gene results in a 100 times reduction in the virulence of V. cholerae in mice.21 Indeed, HlyA has been described as a cause of tissue damage in the small intestinal epithelium of adult mouse infection models.59 The pathogenicity of the ΔtagHΔprtV strain was slightly less than that of the ΔtagH strain in the rabbit loop and septicemia models (Figure 6 and Figure 7), suggesting that PrtV also plays a small role in the pathogenic process. Cases of non-O1/non-O139 V. cholerae sepsis are gradually increasing and the mortality rate is approximately 33%,60 but the main contributing factors to its pathogenesis remain unclear. We found that when compared with the wild-type strain, the ΔtagH mutant was more likely to invade the bloodstream, while the ΔtagHΔhlyA strain rarely entered the bloodstream. (Figure 7b and 7c). In addition, the survival rate of mice infected with the ΔtagH mutant was significantly lower than that of mice infected with the wild-type and ΔtagHΔhlyA strains (Figure 7a). Therefore, our results suggest that HlyA is a key contributing factor in non-O1/non-O139 V. cholerae sepsis. Hemolysin is also considered to be the main contributor to hemorrhagic septicemia, a characteristic of vibriosis.61 We speculate that HlyA can disrupt cell connections, helping bacteria break through the barrier and enter the bloodstream, and leading to disseminated infections. Furthermore, Ou et al. found that HlyA can cause epithelial cell death at high concentrations, while at low concentrations, it can reduce the stability of tight cell junctions.56
Taken together, we propose a hypothetical model in which the secretion of HlyA and the activity of the T6SS is negatively and positively regulated by TagH in V. cholerae, respectively (Figure 9). This study provides evidence to help unravel the regulatory role of TagH in HlyA and the T6SS, expands our understanding of the function of TagH and HlyA, and provides critical insights for the development of strategies to manage HlyA, which plays a key role in the invasion and pathogenesis of V. cholerae. However, this study had some limitations. The intermediate bridge molecule TagH plays a regulatory role that has not yet been identified, and some regulatory details have not been fully elucidated. Future research is required to address the details of the regulation of TagH in the physiological and pathogenic processes of V. cholerae.
Figure 9.

A proposed model showing how the secretion of HlyA and Hcp are negatively and positively regulated by TagH in V. cholerae, respectively. In the normal state (wild-type), TagH promotes T6SS assembly and Hcp secretion, inhibits HlyA transcription through the synergistic effects of HlyU and Fur, and promotes HlyA degradation by PrtV protease. In the tagH knockout state (mutant), the assembly of the T6SS and Hcp secretion were inhibited. The transcription of hlyA was upregulated through the subtle regulation of HlyU and Fur; and the transcription of the prtV gene was downregulated, resulting in the decreased degradation of HlyA. The red arrow represents inhibition and the downward dashed red arrow represents a decrease; The green arrow indicates induction and the upward green dashed arrow represents an increase. IM, inner membrane; OM, outer membrane.
Methods
Bacterial strains and growth conditions
The non-O1/non-O139 V. cholerae HN375 strain was obtained from the China Center for Type Culture Collection (accession number CCTCC AB209168),62 and was used as the wild-type strain in this study. E. coli DH5α, DH5αλpir, BL21(DE3), and WM3064 were used for cloning, expression, and as the donor strains in the conjugative transfer experiments. All strains were cultured in LB with shaking or LB agar at 37°C. The following concentrations of antibiotics: 50 µg/mL kanamycin, 100 µg/mL ampicillin, and 50 µg/mL gentamycin were added to the culture medium for E. coli and V. cholerae when necessary. All bacterial strains and plasmids used in this study are listed in Supplementary Table 2.
DNA manipulations and genetic techniques
All in-frame deletion mutants were constructed from the wild-type HN375 strain using the suicide plasmid pWM91, as described previously.63 All primers used are listed in Supplementary Table 3. To construct the complementary mutants, the entire coding regions of tagH (VCA0112) and prtV (VCA0223) were cloned into the pBAD24 vector,64 and then conjugated into V. cholerae ΔtagH and ΔtagHΔprtV mutants (designated as ΔtagH::tagH and ΔtagHΔprtV::prtV, respectively). In order to supplement the expression of fur in ΔtagH strain, the entire coding region of fur (VC2106) was cloned into the pBAD24 vector, and then conjugated into V. cholerae ΔtagH mutant (designated as ΔtagH+pBAD24-fur). We constructed the S38A, K54A, and S38AK54A point mutations of tagH using site-directed mutagenesis, as was previously described,65 and the templates used were pBAD24-tagH plasmids. The pBAD24-tagHS38AK54A, pBAD24-tagHS38A, and pBAD24-tagHK54A vectors were conjugated to the V. cholerae ΔtagH mutant (designated as ΔtagH::tagHS38A, ΔtagH::tagHK54A, and ΔtagH::tagHS38AK54A, respectively). All complementary strains were cultured in LB medium supplemented with 0.1% arabinose to induce gene expression.
Recombinant protein expression, purification, and preparation of polyclonal antisera
The coding regions of hcp (VC1415) and hlyA (VCA0223) were amplified and cloned into the plasmids pET28a and pCold-TF (Takara), respectively. These recombinant plasmids were transferred into E. coli BL21(DE3) strain for protein expression. The His-tagged recombinant proteins were purified using Ni2+-NTA affinity chromatography, as was previously described.66 To prepare anti-Hcp and anti-HlyA antiserum for Western blotting analysis, 6-week-old Kunming female mice (Experimental Animal Center, Zunyi Medical University) were randomly assigned to each group (n = 10) and raised in a specific pathogen-free (SPF) environment. Mice were immunized subcutaneously with 30 µg of recombinant Hcp and HlyA proteins with an equal volume of aluminum adjuvant on days 1, 14, and 28. Blood samples were collected from the hearts on day 42, and the serum titers were tested by ELISA.
Western blot analysis
All experimental strains were cultured in LB medium or LB with 0.1% arabinose at 37°C with shaking at 220 rpm until the OD600 reached 0.6. Culture supernatants were separated by centrifugation. Secreted proteins were precipitated from 2 mL of culture supernatant using trichloroacetic acid-acetone precipitation, as described previously.67 The conventional samples were separated by SDS-PAGE, and the phosphorylation samples were separated by Phos-tag SDS-PAGE. The Phos-tag SDS-PAGE analysis was carried out according to the Phos-tag acrylamide user manual (Apexbio Technology LLC, USA) with a few modifications. The protein samples were separated on 10% polyacrylamide gel containing 0.375 M Tris-HCl (pH 8.8), 20 µM Phosbind, and 40 µM MnCl2, with electrophoresis conducted at 25–30 mA/gel under a maximum voltage of 120 V. After electrophoresis, the gel was immersed in a transfer buffer containing 10 mM EDTA and gently shaken for at least 10 min. Next, the gel was soaked in an EDTA-free transfer buffer and gently shaken for 10 min. The gel was then washed with transfer buffer containing 1% SDS for 15 min and transferred to PVDF membrane. Immunoblotting was performed with a 1:1000 dilution of anti-Hcp or anti-HlyA (Self-made antibody as described above) or anti-His-tag polyclonal antiserum (Proteintech Group, Inc) as the primary antibody. The HRP-conjugated goat anti-mouse antibody was prepared in a 1:5000 dilution as a secondary antibody. Duplicate gels were run and stained with Coomassie Brilliant Blue to confirm equal loading of the samples. All experiments were repeated thrice for each group.
Quantitative real-time PCR (qRT-PCR)
The wild-type, ΔtagH, and ΔtagH::tagH strains were grown to a mid-exponential phase (OD600 of ~0.6) in LB liquid medium. Cells were pelleted by centrifugation for 2 min at 8000 × g. The total RNA was isolated using the TRIzol Reagent for cDNA synthesis. qRT-PCR assays were performed as was previously described.68 All experiments were repeated thrice for each group.
Hemolytic activity assay
For the blood agar hemolysis test, experimental strains were inoculated on blood agar plates, incubated at 37°C for 24 h, and the diameter of the hemolysis loop was observed. For the culture supernatant hemolysis test, culture supernatants were collected at OD600 ~0.6, and filter sterilized using 0.22 µm filters. A 10% fresh rabbit erythrocyte suspension was prepared by washing and diluting with saline. The culture supernatants and erythrocyte suspensions were mixed at a ratio of 9:1 and incubated at 37°C for 5 h. The supernatant was collected every hour to measure its absorbance at 540 nm. Trion-X (1%) and LB medium were used as positive and negative controls, respectively. The relative hemolysis rate was calculated based on 100% hemolysis with the Triton X-100 control. All experiments were repeated thrice for each group.
Cytotoxicity assay
Cytotoxicity was determined using a CCK-8 assay as described previously.69 SW480 cells in the exponential growth phase were collected and seeded in 96-well plates at a density of 5 × 105 cells per well for 24 h. Culture supernatants of the experimental strains were collected at OD600 ~0.6 and filter sterilized using 0.22 µm. SW480 cells were treated with culture supernatants diluted at 5%, 10%, and 15%, and then cultured at 37°C. LB was used as a negative control. After 8 h, the cells were washed three times with PBS, the medium was replaced with FBS-free medium, then 10 µL of the CCK-8 solution was added, and the cells were incubated at 37°C for 3 h. The absorbance at 450 nm was determined for each well. The relative cell viability was calculated based on the 100% cell viability of the LB medium control. All experiments were repeated thrice for each group.
Luciferase activity analysis
For the luciferase reporter analysis, we modified the pHRP309 plasmid70 and replaced the LacZ reporter gene with the Nluc reporter gene. Putative promoter regions were PCR-amplified and cloned upstream of the Nluc reporter gene. These plasmids were conjugated into the WT, ΔtagH, and ΔtagH::tagH strains, respectively. The strains were then cultivated in LB medium supplemented with 50 µg/mL gentamicin at 37°C with shaking at 220 rpm until the OD600 reached ~0.6. Cell pellets were collected, washed twice with ice-cold PBS, and resuspended in an equal volume of cold PBS. Cells were disrupted using ultrasound, and the resulting cell supernatants were detected using a Nano-Glo luciferase assay kit (Promega). All experiments were repeated three times for each group.
Rabbit ileal loop infection assay
The rabbit ileal loop test was performed as described previously.71 Five New Zealand white rabbits for each group were adaptively fed with sterile water containing 1 mg/1 mL streptomycin for 72 h and fasted for 48 h before surgery with only water available ad libitum. Rabbits were anesthetized by intramuscular injection of tiletamine and zolazepam (0.1 mL/kg body weight) and xylazine hydrochloride injection (0.05 mL/kg body weight). After a celiotomy was performed, the ileal was washed using sterile water and ligated into discrete loops of approximately 6 cm using a sterile surgical line. Each loop was separated into uninoculated segments that were 1–2 cm. Each loop was injected with 1 × 108 CFU of the experimental strain. PBS was used as a negative control. After approximately 18 h, the rabbits were sacrificed using sodium pentobarbital (150 mg/kg body weight), and the peritoneal cavity was opened to remove the loops. The loop fluid volume (mL)/length (cm) ratio was calculated to assess the extent of the fluid accumulation. To further investigate whether these strains caused tissue damage, the tissue from each intestinal test segment was collected, embedded, sectioned, and stained with H&E. Pathological images were acquired with Olympus BX53 microscope containing the cellSens System. The intestinal villus length was then measured using ImageJ software.
Mouse septicemia infection model
Female CD1 mice (6–8 weeks old) were used to construct sepsis models. Mice were randomly assigned to each group (n = 8) and raised in a specific pathogen-free (SPF) environment. Each mouse was intraperitoneally injected with 1 × 107 CFU/100 µL of each experimental strain. Negative control mice were injected with 100 µL of PBS only. Food was then immediately offered to all animals. For the blood cultures, the blood of the mice was collected 6 h and 12 h after infection. After serial dilution, 50 µL of the blood diluent was plated on LB agar and incubated at 37°C for 24 h. The number of colonies on the plates was then calculated. For histopathological observation, mice were sacrificed 12 h after the intraperitoneal injection by cervical dislocation under anesthesia (isoflurane inhalation). The liver, lung, and kidney tissues of the mice were subjected to pathological examination. Pathological images were acquired using the Olympus BX53 microscope containing the cellSens System. For survival experiments, mice were observed for 7 days after the intraperitoneal injection, and the death and survival times were recorded.
Supplementary Material
Acknowledgments
We would like to thank Prof. Kaifeng Wu and Dr. Chengmin Deng from the Third Affiliated Hospital of Zunyi Medical University, for their help with the luciferase activity analysis. We would also like to thank Dr. Yiquan Zhang for kindly providing the pHRP309 plasmid. Finally, we would like to thank Tian Wang, Jianxiong Liu and Yueyue Guo from the college students’ innovation training team for their help with the animal experiments.
Funding Statement
This work was supported by grants from the National Natural Science Foundation of China [No. 31800130, 81760358 and 32060035]; the Science and Technology Project of Zunyi [ZunshikeheHZzi (2019) 91]; and the Science and Technology Project of Guizhou Qiankehejichu-ZK[2021]470
Author contributions
J.H. designed the study. G.W., C.F., H.W., C.J. and X.L. performed the experiments. G.W., J.H., J.Y., T.Z., S.G., and X.M. analyzed data. G.W. and J.H. wrote the paper. X.M. and J.H. conceived and supervised the project.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Ethics statement
All animal experiments were approved by the Ethics Committee at the Affiliated Hospital of Zunyi Medical University (Permit Number: KLL-2020-079) in accordance with the Regulations for the Administration of Affairs Concerning Experimental Animals.
Data availability
The data that support the findings of this study are available in “figshare” at a pre-registered DOI (http://10.6084/m9.figshare.16912660) and the reviewer URL https://figshare.com/s/571cc7fa349472c33f3d.
Statistical analysis
Statistical analyses were performed using Prism (version 8) software (GraphPad Software, USA). The differences between two groups were analyzed using unpaired two-tailed Student’s t-test. Survival data were analyzed using the log-rank (Mantel-Cox) test. P < .05 was considered significant. All experiments were performed on at least three independent replicates, and the values are expressed as the mean ± SD.
Supplementary material
Supplemental data for this article can be accessed on the publisher’s website
References
- 1.Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren JC.. Cholera. Lancet (London, England). 2017;390(10101):1539–18. doi: 10.1016/S0140-6736(17)30559-7. [DOI] [PubMed] [Google Scholar]
- 2.Qin Z, Yang X, Chen G, Park C, Liu Z. Crosstalks between gut microbiota and Vibrio cholerae. Front Cell Infect Microbiol. 2020;10:582554. doi: 10.3389/fcimb.2020.582554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kaper JB, Jg M Jr, Levine MM. Cholera. Clin Microbiol Rev. 1995;8:48–86. doi: 10.1128/CMR.8.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zhang X, Lu Y, Qian H, Liu G, Mei Y, Jin F, Xia W, Ni F. Non-O1, Non-O139 Vibrio cholerae (NOVC) bacteremia: case report and literature review, 2015-2019. Infect Drug Resist. 2020;13:1009–1016. doi: 10.2147/IDR.S245806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dobrović K, Rudman F, Ottaviani D, Šestan Crnek S, Leoni F, Škrlin J. A rare case of necrotizing fasciitis caused by Vibrio cholerae O8 in an immunocompetent patient. Wien Klin Wochenschr. 2016;128:728–730. doi: 10.1007/s00508-016-1060-3. [DOI] [PubMed] [Google Scholar]
- 6.Hao Y, Wang Y, Bi Z, Sun B, Jin Y, Bai Y, Chen B, Shao C, Sun X, Lu Z. A case of non-O1/non-O139 Vibrio cholerae septicemia and meningitis in a neonate. Int J Infect Dis. 2015;35:117–119. doi: 10.1016/j.ijid.2015.05.004. [DOI] [PubMed] [Google Scholar]
- 7.Ismail EA, Shafik MH, Al-Mutairi G. A case of non-O:1 Vibrio cholerae septicemia with meningitis, cerebral abscess and unilateral hydrocephalus in a preterm baby. Eur J Clin Microbiol Infect Dis. 2001;20:598–600. doi: 10.1007/s100960100553. [DOI] [PubMed] [Google Scholar]
- 8.Sarwar S, Hannan A, Sultana Q, Saleem S, Sohail M, Arshad MU, Rasool K. Non-O1Vibrio cholerae bacteremia in an infant, first case report from Pakistan. J Infect Dev Ctries. 2016;10:188–189. doi: 10.3855/jidc.6554. [DOI] [PubMed] [Google Scholar]
- 9.Arteaga M, Velasco J, Rodriguez S, Vidal M, Arellano C, Silva F, Carreño LJ, Vidal R, Montero DA. Genomic characterization of the non-O1/non-O139 Vibrio cholerae strain that caused a gastroenteritis outbreak in Santiago, Chile, 2018. Microb Genom. 2020;6(3):e000340. doi: 10.1099/mgen.0.000340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dutta D, Chowdhury G, Pazhani GP, Guin S, Dutta S, Ghosh S, Rajendran K, Nandy RK, Mukhopadhyay AK, Bhattacharya MK, et al. Vibrio cholerae non-O1, non-O139 serogroups and cholera-like diarrhea, Kolkata, India. Emerg Infect Dis. 2013;19:464–467. doi: 10.3201/eid1903.121156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gallego-Hernandez AL, DePas WH, Park JH, Teschler JK, Hartmann R, Jeckel H, Drescher K, Beyhan S, Newman DK, Yildiz FH. Upregulation of virulence genes promotes Vibrio cholerae biofilm hyperinfectivity. Proc Natl Acad Sci U S A. 2020;117:11010–11017. doi: 10.1073/pnas.1916571117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Baek Y, Lee D, Lee J, Yoon Y, Nair GB, Kim DW, Kim EJ. Cholera toxin production in Vibrio cholerae O1 El Tor biotype strains in single-phase culture. Front Microbiol. 2020;11:825. doi: 10.3389/fmicb.2020.00825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cinar HN, Kothary M, Datta AR, Tall BD, Sprando R, Bilecen K, Yildiz F, McCardell B. Vibrio cholerae hemolysin is required for lethality, developmental delay, and intestinal vacuolation in Caenorhabditis elegans. PLoS One. 2010;5:e11558. doi: 10.1371/journal.pone.0011558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hirsch N, Kappe E, Gangl A, Schwartz K, Mayer-Scholl A, Hammerl JA, Strauch E. Phenotypic and genotypic properties of Vibrio cholerae non-O1, non-O139 isolates recovered from domestic ducks in Germany. Microorganisms. 2020;8:1104. doi: 10.3390/microorganisms8081104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Shin OS, Tam VC, Suzuki M, Ritchie JM, Bronson RT, Waldor MK, Mekalanos JJ. Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 Vibrio cholerae. mBio. 2011;2:e00106–00111. doi: 10.1128/mBio.00106-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.De S, Olson R. Crystal structure of the Vibrio cholerae cytolysin heptamer reveals common features among disparate pore-forming toxins. Proc Natl Acad Sci U S A. 2011;108:7385–7390. doi: 10.1073/pnas.1017442108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.De S, Kaus K, Sinclair S, Case BC, Olson R. Structural basis of mammalian glycan targeting by Vibrio cholerae cytolysin and biofilm proteins. PLoS Pathog. 2018;14:e1006841. doi: 10.1371/journal.ppat.1006841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gutierrez MG, Saka HA, Chinen I, Zoppino FC, Yoshimori T, Bocco JL, Colombo MI. Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc Natl Acad Sci U S A. 2007;104:1829–1834. doi: 10.1073/pnas.0601437104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Moschioni M, Tombola F, de Bernard M, Coelho A, Zitzer A, Zoratti M, Montecucco C. The Vibrio cholerae haemolysin anion channel is required for cell vacuolation and death. Cell Microbiol. 2002;4:397–409. doi: 10.1046/j.1462-5822.2002.00199.x. [DOI] [PubMed] [Google Scholar]
- 20.Sahu SN, Lewis J, Patel I, Bozdag S, Lee JH, LeClerc JE, Cinar HN. Genomic analysis of immune response against Vibrio cholerae hemolysin in Caenorhabditis elegans. PLoS One. 2012;7:e38200. doi: 10.1371/journal.pone.0038200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Olivier V, Haines GK 3rd, Tan Y, Satchell KJ. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains. Infect Immun. 2007;75:5035–5042. doi: 10.1128/IAI.00506-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ruenchit P, Reamtong O, Siripanichgon K, Chaicumpa W, Diraphat P. New facet of non-O1/non-O139 Vibrio cholerae hemolysin A: a competitive factor in the ecological niche. FEMS Microbiol Ecol. 2017;93:fix113. doi: 10.1093/femsec/fix113. [DOI] [PubMed] [Google Scholar]
- 23.Crisan CV, Chande AT, Williams K, Raghuram V, Rishishwar L, Steinbach G, Watve SS, Yunker P, Jordan IK, Hammer BK. Analysis of Vibrio cholerae genomes identifies new type VI secretion system gene clusters. Genome Biol. 2019;20:163. doi: 10.1186/s13059-019-1765-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cherrak Y, Flaugnatti N, Durand E, Journet L, Cascales E. Structure and activity of the Type VI secretion system. Microbiol Spectr. 2019;7. doi: 10.1128/microbiolspec.PSIB-0031-2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Joshi A, Kostiuk B, Rogers A, Teschler J, Pukatzki S, Yildiz FH. Rules of engagement: the Type VI Secretion System in Vibrio cholerae. Trends Microbiol. 2017;25:267–279. doi: 10.1016/j.tim.2016.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wang J, Brodmann M, Basler M. Assembly and subcellular localization of bacterial Type VI secretion systems. Annu Rev Microbiol. 2019;73:621–638. doi: 10.1146/annurev-micro-020518-115420. [DOI] [PubMed] [Google Scholar]
- 27.MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S. The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci U S A. 2010;107:19520–19524. doi: 10.1073/pnas.1012931107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, Heidelberg JF, Mekalanos JJ. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A. 2006;103:1528–1533. doi: 10.1073/pnas.0510322103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fu Y, Waldor MK, Mekalanos JJ. Tn-seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe. 2013;14:652–663. doi: 10.1016/j.chom.2013.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Durocher D, Jackson SP. The FHA domain. FEBS Lett. 2002;513:58–66. doi: 10.1016/s0014-5793(01)03294-x. [DOI] [PubMed] [Google Scholar]
- 31.Almawi AW, Matthews LA, Guarné A. FHA domains: phosphopeptide binding and beyond. Prog Biophys Mol Biol. 2017;127:105–110. doi: 10.1016/j.pbiomolbio.2016.12.003. [DOI] [PubMed] [Google Scholar]
- 32.Panni S. Phospho-peptide binding domains in S. cerevisiae model organism. Biochimie. 2019;163:117–127. doi: 10.1016/j.biochi.2019.06.005. [DOI] [PubMed] [Google Scholar]
- 33.Mougous JD, Gifford CA, Ramsdell TL, Mekalanos JJ. Threonine phosphorylation post-translationally regulates protein secretion in Pseudomonas aeruginosa. Nat Cell Biol. 2007;9:797–803. doi: 10.1038/ncb1605. [DOI] [PubMed] [Google Scholar]
- 34.Ostrowski A, Cianfanelli FR, Porter M, Mariano G, Peltier J, Wong JJ, Swedlow JR, Trost M, Coulthurst SJ. Killing with proficiency: integrated post-translational regulation of an offensive Type VI secretion system. PLoS Pathog. 2018;14:e1007230. doi: 10.1371/journal.ppat.1007230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Boyer F, Fichant G, Berthod J, Vandenbrouck Y, Attree I. Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: what can be learned from available microbial genomic resources. BMC Genomics. 2009;10:104. doi: 10.1186/1471-2164-10-104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pallen M, Chaudhuri R, Khan A. Bacterial FHA domains: neglected players in the phospho-threonine signalling game. Trends Microbiol. 2002;10:556–563. doi: 10.1016/s0966-842x(02)02476-9. [DOI] [PubMed] [Google Scholar]
- 37.Zheng J, Ho B, Mekalanos JJ. Genetic analysis of anti-amoebae and anti-bacterial activities of the type VI secretion system in Vibrio cholerae. PLoS One. 2011;6:e23876. doi: 10.1371/journal.pone.0023876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Khilwani B, Chattopadhyay K. Signaling beyond punching holes: modulation of cellular responses by Vibrio cholerae cytolysin. Toxins (Basel). 2015;7:3344–3358. doi: 10.3390/toxins7083344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Stietz MS, Liang X, Li H, Zhang X, Dong TG. TssA-TssM-TagA interaction modulates type VI secretion system sheath-tube assembly in Vibrio cholerae. Nat Commun. 2020;11:5065. doi: 10.1038/s41467-020-18807-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Nagamune K, Yamamoto K, Naka A, Matsuyama J, Miwatani T, Honda T. In vitro proteolytic processing and activation of the recombinant precursor of El Tor cytolysin/hemolysin (pro-HlyA) of Vibrio cholerae by soluble hemagglutinin/protease of V. cholerae, trypsin, and other proteases. Infect Immun. 1996;64:4655–4658. doi: 10.1128/iai.64.11.4655-4658.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Valeva A, Walev I, Weis S, Boukhallouk F, Wassenaar TM, Endres K, Fahrenholz F, Bhakdi S, Zitzer A. A cellular metalloproteinase activates Vibrio cholerae pro-cytolysin. J Biol Chem. 2004;279:25143–25148. doi: 10.1074/jbc.M313913200. [DOI] [PubMed] [Google Scholar]
- 42.Gao H, Xu J, Lu X, Li J, Lou J, Zhao H, Diao B, Shi Q, Zhang Y, Kan B. Expression of hemolysin is regulated under the collective actions of HapR, Fur, and HlyU in Vibrio cholerae El Tor serogroup O1. Front Microbiol. 2018;9:1310. doi: 10.3389/fmicb.2018.01310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Tsou AM, Zhu J. Quorum sensing negatively regulates hemolysin transcriptionally and posttranslationally in Vibrio cholerae. Infect Immun. 2010;78(1):461–467. doi: 10.1128/IAI.00590-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Stoebner JA, Payne SM. Iron-regulated hemolysin production and utilization of heme and hemoglobin by Vibrio cholerae. Infect Immun. 1988;56:2891–2895. doi: 10.1128/iai.56.11.2891-2895.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Mukherjee D, Pal A, Chakravarty D, Chakrabarti P. Identification of the target DNA sequence and characterization of DNA binding features of HlyU, and suggestion of a redox switch for hlyA expression in the human pathogen Vibrio cholerae from in silico studies. Nucleic Acids Res. 2015;43:1407–1417. doi: 10.1093/nar/gku1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Williams SG, Attridge SR, Manning PA. The transcriptional activator HlyU of Vibrio cholerae: nucleotide sequence and role in virulence gene expression. Mol Microbiol. 1993;9:751–760. doi: 10.1111/j.1365-2958.1993.tb01735.x. [DOI] [PubMed] [Google Scholar]
- 47.Williams SG, Manning PA. Transcription of the Vibrio cholerae haemolysin gene, hlyA, and cloning of a positive regulatory locus, hlyU. Mol Microbiol. 1991;5:2031–2038. doi: 10.1111/j.1365-2958.1991.tb00825.x. [DOI] [PubMed] [Google Scholar]
- 48.Mahajan A, Yuan C, Lee H, Chen ES, Wu PY, Tsai MD. Structure and function of the phosphothreonine-specific FHA domain. Sci Signal. 2008;1:re12. doi: 10.1126/scisignal.151re12. [DOI] [PubMed] [Google Scholar]
- 49.Lin JS, Wu HH, Hsu PH, Ma LS, Pang YY, Tsai MD, Lai EM. Fha interaction with phosphothreonine of TssL activates type VI secretion in Agrobacterium tumefaciens. PLoS Pathog. 2014;10:e1003991. doi: 10.1371/journal.ppat.1003991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Hsu F, Schwarz S, Mougous JD. TagR promotes PpkA-catalysed type VI secretion activation in Pseudomonas aeruginosa. Mol Microbiol. 2009;72:1111–1125. doi: 10.1111/j.1365-2958.2009.06701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Fritsch MJ, Trunk K, Diniz JA, Guo M, Trost M, Coulthurst SJ. Proteomic identification of novel secreted antibacterial toxins of the Serratia marcescens type VI secretion system. Mol Cell Proteomics. 2013;12:2735–2749. doi: 10.1074/mcp.M113.030502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Williams SG, Varcoe LT, Attridge SR, Manning PA. Vibrio cholerae Hcp, a secreted protein coregulated with HlyA. Infect Immun. 1996;64:283–289. doi: 10.1128/iai.64.1.283-289.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mizuno T, Sultan SZ, Kaneko Y, Yoshimura T, Maehara Y, Nakao H, Tsuchiya T, Shinoda S, Miyoshi S. Modulation of Vibrio mimicus hemolysin through limited proteolysis by an endogenous metalloprotease. FEBS J. 2009;276:825–834. doi: 10.1111/j.1742-4658.2008.06827.x. [DOI] [PubMed] [Google Scholar]
- 54.Edwin A, Grundström C, Wai SN, Ohman A, Stier G, Sauer-Eriksson AE. Domain isolation, expression, purification and proteolytic activity of the metalloprotease PrtV from Vibrio cholerae. Protein Expr Purif. 2014;96:39–47. doi: 10.1016/j.pep.2014.01.012. [DOI] [PubMed] [Google Scholar]
- 55.Edwin A, Rompikuntal P, Björn E, Stier G, Wai SN, Sauer-Eriksson AE. Calcium binding by the PKD1 domain regulates interdomain flexibility in Vibrio cholerae metalloprotease PrtV. FEBS Open Bio. 2013;3:263–270. doi: 10.1016/j.fob.2013.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ou G, Rompikuntal PK, Bitar A, Lindmark B, Vaitkevicius K, Wai SN, Hammarström ML. Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease. PLoS One. 2009;4:e7806. doi: 10.1371/journal.pone.0007806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Ichinose Y, Yamamoto K, Nakasone N, Tanabe MJ, Takeda T, Miwatani T, Iwanaga M. Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect Immun. 1987;55:1090–1093. doi: 10.1128/iai.55.5.1090-1093.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Alm RA, Mayrhofer G, Kotlarski I, Manning PA. Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic. Vaccine. 1991;9:588–594. doi: 10.1016/0264-410x(91)90247-4. [DOI] [PubMed] [Google Scholar]
- 59.Saka HA, Bidinost C, Sola C, Carranza P, Collino C, Ortiz S, Echenique JR, Bocco JL. Vibrio cholerae cytolysin is essential for high enterotoxicity and apoptosis induction produced by a cholera toxin gene-negative V. cholerae non-O1, non-O139 strain. Microb Pathog. 2008;44:118–128. doi: 10.1016/j.micpath.2007.08.013. [DOI] [PubMed] [Google Scholar]
- 60.Deshayes S, Daurel C, Cattoir V, Parienti JJ, Quilici ML, de La Blanchardière A. Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. Springerplus. 2015;4:575. doi: 10.1186/s40064-015-1346-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Jiang F, Bi R, Deng L, Kang H, Gu B, Ma P. Virulence-associated genes and molecular characteristics of non-O1/non-O139 Vibrio cholerae isolated from hepatitis B cirrhosis patients in China. Int J Infect Dis. 2018;74:117–122. doi: 10.1016/j.ijid.2018.06.021. [DOI] [PubMed] [Google Scholar]
- 62.Luo P, Su T, Hu C, Ren C. A novel and simple PCR walking method for rapid acquisition of long DNA sequence flanking a known site in microbial genome. Mol Biotechnol. 2011;47:220–228. doi: 10.1007/s12033-010-9332-z. [DOI] [PubMed] [Google Scholar]
- 63.Wu R, Zhao M, Li J, Gao H, Kan B, Liang W. Direct regulation of the natural competence regulator gene tfoX by cyclic AMP (cAMP) and cAMP receptor protein (CRP) in Vibrios. Sci Rep. 2015;5:14921. doi: 10.1038/srep14921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Sun F, Zhang Y, Qiu Y, Yang H, Yang W, Yin Z, Wang J, Yang R, Xia P, Zhou D. H-NS is a repressor of major virulence gene loci in Vibrio parahaemolyticus. Front Microbiol. 2014;5:675. doi: 10.3389/fmicb.2014.00675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Fisher CL, Pei GK. Modification of a PCR-based site-directed mutagenesis method. Biotechniques. 1997;23:570–571, 574. doi: 10.2144/97234bm01. [DOI] [PubMed] [Google Scholar]
- 66.Huang J, Zhang Q, Chen J, Zhang T, Chen Z, Chen Z, Yang J, Wang Y, Min Z, Huang M, et al. Neisseria gonorrhoeae NGO2105 is an autotransporter protein involved in adhesion to human cervical epithelial cells and in vivo colonization. Front Microbiol. 2020;11:1395. doi: 10.3389/fmicb.2020.01395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Nguyen AN, Disconzi E, Charrière GM, Destoumieux-Garzón D, Bouloc P, Le Roux F, Jacq A. csrB gene duplication drives the evolution of redundant regulatory pathways controlling expression of the major toxic secreted metalloproteases in Vibrio tasmaniensis LGP32. mSphere. 2018;3:e00582–18. doi: 10.1128/mSphere.00582-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Huang J, Chen Y, Chen J, Liu C, Zhang T, Luo S, Huang M, Min X. Exploration of the effects of a degS mutant on the growth of Vibrio cholerae and the global regulatory function of degS by RNA sequencing. PeerJ. 2019;7:e7959. doi: 10.7717/peerj.7959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Zhang MQ, Chen B, Zhang JP, Chen N, Liu CZ, Hu CQ. Liver toxicity of macrolide antibiotics in zebrafish. Toxicology. 2020;441:152501. doi: 10.1016/j.tox.2020.152501. [DOI] [PubMed] [Google Scholar]
- 70.Parales RE, Harwood CS. Construction and use of a new broad-host-range lacZ transcriptional fusion vector, pHRP309, for gram- bacteria. Gene. 1993;133:23–30. doi: 10.1016/0378-1119(93)90220-w. [DOI] [PubMed] [Google Scholar]
- 71.Ghosh P, Sinha R, Samanta P, Saha DR, Koley H, Dutta S, Okamoto K, Ghosh A, Ramamurthy T, Mukhopadhyay AK. Haitian variant Vibrio cholerae O1 strains manifest higher virulence in animal models. Front Microbiol. 2019;10:111. doi: 10.3389/fmicb.2019.00111. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that support the findings of this study are available in “figshare” at a pre-registered DOI (http://10.6084/m9.figshare.16912660) and the reviewer URL https://figshare.com/s/571cc7fa349472c33f3d.
